Position in PCVX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,896,300
-$61,790,983 QoQ
Shares Held
101,433
-91.3% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#100
of 329 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. PCVX ranks #33 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in PCVX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,896,300 | 101,433 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $67,687,283 | 1,164,813 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $25,133,749 | 544,728 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,922,599 | 219,950 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,559,699 | 47,976 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $12,217,814 | 323,565 | Shares | Sole | 2025-04-15 | |
| 2024-06-30 | $213,391 | 2,826 | Shares | Sole | 2024-07-18 | |
| No filing history on record for this holder in this stock. | ||||||